Hearing Loss/Deafness Multi-Gene Panel
method(s): ◦ Sequencing, Next Gen
Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
OtoGenome™ Test for Hearing Loss and Related Syndromes (87 Genes)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine - Cambridge, MA, USA |
Dilated Cardiomyopathy Panel
method(s): ◦ Sequencing, Next Gen
ApolloGen, Inc. - Irvine, CA, USA |
Comprehensive Cardiomyopathy Panel
method(s): ◦ Sequencing, Next Gen
ApolloGen, Inc. - Irvine, CA, USA |
Hearing Loss Panel Tier 1
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger)
Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA |
Hearing Loss Mitochondrial DNA Panel
method(s): ◦ Sequencing, Capillary (Sanger)
Cincinnati Children's Hospital Medical Center, Molecular Genetics Laboratory - Cincinnati, OH, USA |
MTRNL Inherited Hearing Loss
method(s): ◦ Sequencing, Capillary (Sanger)
Baylor Miraca Genetics Laboratories - Houston, TX, USA |
MTRNL Inherited Hearing Loss
method(s): ◦ Sequencing, Capillary (Sanger)
Baylor Miraca Genetics Laboratories - Houston, TX, USA |
Hearing Loss: Targeted Mitochondrial Mutation Panel
method(s):
Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Hearing Loss: Aminoglycoside-Induced Mitochondrial Deafness
method(s): ◦ Sequencing, Capillary (Sanger)
Hospital for Sick Children, Genome Diagnostics Laboratory (formerly Molecular Genetics Laboratory) - Toronto, Canada |
MTTS1 Gene Sequencing
method(s): ◦ Sequencing, Capillary (Sanger)
Center for Human Genetics and Laboratory Medicine Martinsried, Molecular Genetics - Martinsried, Germany |
mtSEEK® Mitochondrial Genome Sequencing
method(s): ◦ Sequencing, Next Gen
Courtagen Life Sciences, Courtagen Diagnostics Laboratory - Woburn, MA, USA |
DCM/LVNC Sequencing Panel
method(s): ◦ Sequencing, Next Gen
GeneDx - Gaithersburg, MD, USA |
Comprehensive Cardiomyopathy Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
GeneDx - Gaithersburg, MD, USA |
TAT: 12-16 weeks
price: $1,500.00
OtoSCOPE
method(s): ◦ Sequencing, Next Gen
University of Iowa Hospital and Clinics, Molecular Otolaryngology and Renal Research Laboratories - Iowa City, IA, USA |
TAT: 8-9 weeks
price: $168.00
MTTS1
method(s): ◦ Sequencing, Capillary (Sanger)
University of Iowa Hospital and Clinics, Molecular Otolaryngology and Renal Research Laboratories - Iowa City, IA, USA |
Mitochondrial Type MERRF Encephalopathy , Related Mutations
method(s): ◦ Mutation Scanning of Entire Coding Region
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Mitochondrial Type MELAS Encephalopathy , Related Mutations
method(s): ◦ Mutation Scanning of Entire Coding Region
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Hearing Loss, Nonsyndromic Panel (GJB2) Sequencing, (GJB6) 2 Deletions and Mitochondrial DNA 2 Mutations
method(s): ◦ Sequencing, Capillary (Sanger)
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Hearing Loss, Nonsyndromic, Mitochondrial DNA 2 Mutations
method(s): ◦ Sequencing, Capillary (Sanger)
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Mitochondrial Disorders (mtDNA) Sequencing
method(s): ◦ Sequencing, Next Gen
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Mitochondrial Disorders Panel (mtDNA Sequencing and Deletion/Duplication, 121 Nuclear Genes Sequencing, 119 Nuclear Genes Deletion/Duplication)
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
Cardiomyopathy, Dilated (DCM)
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Usher Syndrome and Non-Syndromic Deafness
method(s): ◦ Sequencing, Next Gen
GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Mitochondrial Cardiomyopathy Test
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Mitochondrial Disorders Test
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger)
MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
mtDNA encoded Mitochondriopathies Panel
method(s): ◦ Sequencing, Next Gen
CeGaT GmbH - Tübingen, Germany |
Mitochondrial Disorders, Panel Massive Sequencing 37 Genes
method(s): ◦ Sequencing, Next Gen
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
NewbornDx
method(s): ◦ Sequencing, Next Gen
Parabase Genomics - Boston, MA, USA |
NewbornDx HL
method(s): ◦ Sequencing, Next Gen
Parabase Genomics - Boston, MA, USA |
MERRF/MELAS overlap syndrome (sequence analysis of MTTS1 gene)
method(s): ◦ Sequencing, Capillary (Sanger)
CGC Genetics - Porto, Portugal |
Hearing Loss: GJB2 and GJB6 Sequencing, GJB6 Common Deletion, and Targeted Mitochondrial Analysis Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Hearing Loss: Targeted Mitochondrial Mutation Panel
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen
CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
NGS Hearing Loss Panel
method(s): ◦ Sequencing, Next Gen
Greenwood Genetic Center Diagnostic Laboratories - Greenwood, SC, USA |
MELAS syndrome (MELAS)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
Myoclonic Epilepsy associated with Ragged-red Fibers (MERRF)
method(s): ◦ Sequencing, Next Gen
Praxis fuer Humangenetik Wien - Vienna, Austria |
TAT: 4 weeks
price: $1,245.00
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel
method(s): ◦ Sequencing, Next Gen
Otogenetics Corporation - Atlanta, GA, USA |
MERRF/MELAS overlap syndrome, MT-TS1 related
method(s): ◦ Sequencing, Capillary (Sanger)
Centogene AG, Rare Disease Company - Rostock, Germany |
Mitochondrial Genome NGS Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen
Fulgent Diagnostics - Temple City, CA, USA |
CentoMito™ Genome
method(s): ◦ Sequencing, Next Gen
Centogene AG, Rare Disease Company - Rostock, Germany |
